1. Home
  2. PSN vs RGEN Comparison

PSN vs RGEN Comparison

Compare PSN & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Parsons Corporation

PSN

Parsons Corporation

HOLD

Current Price

$52.99

Market Cap

5.6B

Sector

Technology

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$114.24

Market Cap

8.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PSN
RGEN
Founded
1944
1981
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.6B
8.1B
IPO Year
2019
1995

Fundamental Metrics

Financial Performance
Metric
PSN
RGEN
Price
$52.99
$114.24
Analyst Decision
Strong Buy
Buy
Analyst Count
13
11
Target Price
$83.50
$175.64
AVG Volume (30 Days)
1.2M
806.3K
Earning Date
04-29-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
3.77
286.96
EPS
2.20
0.86
Revenue
$6,364,245,000.00
$141,236,000.00
Revenue This Year
$6.08
$14.31
Revenue Next Year
$7.63
$14.41
P/E Ratio
$24.46
$132.66
Revenue Growth
N/A
35.10
52 Week Low
$49.38
$102.97
52 Week High
$89.50
$175.77

Technical Indicators

Market Signals
Indicator
PSN
RGEN
Relative Strength Index (RSI) 37.68 33.96
Support Level N/A $112.53
Resistance Level $66.57 $132.51
Average True Range (ATR) 2.22 4.93
MACD -0.18 0.64
Stochastic Oscillator 26.84 12.76

Price Performance

Historical Comparison
PSN
RGEN

About PSN Parsons Corporation

Parsons Corp is a provider of technology-driven solutions in the defense, intelligence, and critical infrastructure markets. The business activities of the group are carried out through Federal Solutions and Critical Infrastructure segments. The Federal Solutions segment is a high-end service and technology provider to the U.S. government, delivering timely, cost-effective solutions for mission-critical projects, whereas the Critical Infrastructure segment provides integrated design and engineering services for complex physical and digital infrastructure around the globe. The company derives maximum revenue from Federal Solutions segment. Geographically, the company derives revenue from North America; Middle East; and Rest of the World, of which North America derives maximum revenue.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: